Efficacy of transarterial chemoembolization on lesion reduction in colorectal liver metastases

Acta Medica Iranica

Volumn 50, Issue 8, 2012, Pages 535-540

  Ghanaati, Hossein ^a   Mohammadzadeh, Vahid ^b   Mohammadzadeh, Ali ^b   Firouznia, Kavous ^a   Mohammadzadeh, Maryam ^c   Motevali, Marzieh ^b   Kadivar, Sakineh ^d   Mohammadzadeh, Mohammad Ali ^d   Dargahi, Abbas ^a   Jalali, Amir Hossein ^a   Shakiba, Madjid ^a   Azadeh, Payam ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemotherapy; Colorectal carcinoma; Liver metastases; Transarterial chemoembolization

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN; CEFTRIAXONE; CREATININE; DOXORUBICIN; GRANISETRON; IODINATED POPPYSEED OIL; METOCLOPRAMIDE; MITOMYCIN; RANITIDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CELL COUNT; CANCER COMBINATION CHEMOTHERAPY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMAGE ANALYSIS; INFECTION; INFECTION PREVENTION; LIVER METASTASIS; MALE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84868289683     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Vogl TJ, Zangos S, Eichler K, Yakoub D, Nabil M. Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update. Eur Radiol 2007;17(4):1025-34.
2. Cohen AD, Kemeny NE. An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 2003;8(6):553-66.
3. Bentrem DJ, Dematteo RP, Blumgart LH. Surgical therapy for metastatic disease to the liver. Annu Rev Med 2005;56:139-56.
4. Ji SH, Park YS, Lee J, Lim DH, Park BB, Park KW, Kang JH, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Im YH, Kang WK, Park K. Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer. Jpn J Clin Oncol 2005;35(4):214-7.
5. Kuehr T, Ruff P, Rapoport BL, Falk S, Daniel F, Jacobs C, Davidson N, Thaler J, Boussard B, Carmichael J. Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer. BMC Cancer 2004;4:36.
6. Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. J Clin Oncol 2004;22(23):4753-61.
7. Germer CT, Buhr HJ, Isbert C. Nonoperative ablation for liver metastases. Possibilities and limitations as a curative treatment. Chirurg 2005;76(6):552-4, 556-63.
8. Bavisotto LM, Patel NH, Althaus SJ, Coldwell DM, Nghiem HV, Thompson T, Storer B, Thomas CR Jr. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104). Clin Cancer Res 1999;5(1):95-109.
9. Dudeck O, Ricke J. Advances in regional chemotherapy of the liver. Expert Opin Drug Deliv 2011;8(8):1057-69.
10. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954;30(5):969-977.
11. Wallace S, Carrasco CH, Charnsangavej C, Richli WR, Wright K, Gianturco C. Hepatic artery infusion and chemoembolization in the management of liver metastases. Cardiovasc Intervent Radiol 1990;13(3):153-60.
12. Vogl TJ, Mack MG, Balzer JO, Engelmann K, Straub R, Eichler K, Woitaschek D, Zangos S. Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy. Radiology 2003;229(2):457-64.
13. Bläker H, Hofmann WJ, Theuer D, Otto HF. Pathohistological findings in liver metastases. Radiologe 2001;41(1):1-7.
14. You YT, Changchien CR, Huang JS, Ng KK. Combining systemic chemotherapy with chemoembolization in the treatment of unresectable hepatic metastases from colorectal cancer. Int J Colorectal Dis 2006;21(1):33-7.
15. Lewis AL, Gonzalez MV, Lloyd AW, Hall B, Tang Y, Willis SL, Leppard SW, Wolfenden LC, Palmer RR, Stratford PW. DC bead: in vitro characterization of a drugdelivery device for transarterial chemoembolization. J Vasc Interv Radiol 2006;17(2 Pt 1):335-42.
16. Aliberti C, Tilli M, Benea G, Fiorentini G. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res 2006;26(5B):3793-5.
17. Fiorentini G, Aliberti C, Turrisi G, Del Conte A, Rossi S, Benea G, Giovanis P. Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study. In Vivo 2007;21(6):1085-91.
18. Martin RC, Joshi J, Robbins K, Tomalty D, O'Hara R, Tatum C. Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry. J Oncol 2009;2009:539795.
19. Martin RC, Robbins K, Tomalty D, O'Hara R, Bosnjakovic P, Padr R, Rocek M, Slauf F, Scupchenko A, Tatum C. Transarterial chemoembolisation (TACE) using irinotecanloaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol 2009;7:80.
20. Sacco R, Bertini M, Petruzzi P, Bertoni M, Bargellini I, Bresci G, Federici G, Gambardella L, Metrangolo S, Parisi G, Romano A, Scaramuzzino A, Tumino E, Silvestri A, Altomare E, et al. Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: a cohort study. World J Gastroenterol 2009;15(15):1843-8.
21. Vogl TJ, Gruber T, Balzer JO, Eichler K, Hammerstingl R, Zangos S. Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. Radiology 2009;250(1):281-9.
22. Müller H, Nakchbandi V, Chatzisavvidis I, von Voigt C. Repetitive chemoembolization with melphalan plus intraarterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GMCSF) as effective first-and second-line treatment of disseminated colorectal liver metastases. Hepatogastroenterology 2003;50(54):1919-26.
23. Voigt W, Behrmann C, Schlueter A, Kegel T, Grothey A, Schmoll HJ. A new chemoembolization protocol in refractory liver metastasis of colorectal cancer: a feasibility study. Onkologie 2002;25(2):158-64.